مقالات به زبان انگلیسی

پرینت

Researchers aim to repurpose former experimental cancer therapy to treat muscular dystrophy

نوشته شده توسط National Institutes of Health (NIH) در .

June 13, 2017

Researchers at the National Institutes of Health’s National Center for Advancing Translational Sciences (NCATS) and the University of Nevada, Reno School of Medicine (UNR Med) have demonstrated that a drug originally targeted unsuccessfully to treat cancer may have new life as a potential treatment for Duchenne muscular dystrophy (DMD).